Browse by Title

Type here to filter the list

I
Immunotherapy for Soft-Tissue Sarcoma

Christina L. Roland, MD MS – The University of Texas MD Anderson Cancer Center ### 894415###Moderator###Associate Professor of Surgical Oncology###The University of Texas MD Anderson Cancer Center###
Moderator: Christina L. Roland, MD MS – The University of Texas MD Anderson Cancer Center
###
Impact of patient-associated risk factors on adequate lymph node counts in patients with gastric adenocarcinoma (GPP8)

Dario E. Cantú Esparza, Surgical Oncologist (he/him/his) – Hospital General de México ### 2269655###Poster Presenter###Surgical Oncologist###Hospital General de México###
Poster Presenter: Dario E. Cantú Esparza, Surgical Oncologist (he/him/his) – Hospital General de México
### he/him/his GPP8
Implementing Novel Complex Surgical Procedures into a Community Practice

Mohammad Al Efishat, MD, FSSO – LSU/ Our Lady of the Lake Regional Medical Center ### 2119262###Presenter###Surgical Oncologist/ Clinical Assistant Professor of Surgery###LSU/ Our Lady of the Lake Regional Medical Center###
Presenter: Mohammad Al Efishat, MD, FSSO – LSU/ Our Lady of the Lake Regional Medical Center
###
Incorporating Palliative Care Across the Cancer Spectrum
Incorporation of Technology in Cancer Surgery

Daniel A. Anaya, MD, MSHCT – Moffitt Cancer Center ### 1795359###Breakout Presenter###Professor and Chief, GI Surgery. Head - Hepatobiliary Section###Moffitt Cancer Center###
Breakout Presenter: Daniel A. Anaya, MD, MSHCT – Moffitt Cancer Center
###
Industry Forum Breakfast: AstraZeneca:Germline BRCA Mutation Testing in Breast Cancer to Help Inform Clinical Decisions

Sara Beeler ### 2275110###Industry Presenter#########
Industry Presenter: Sara Beeler
###
Industry Forum Breakfast: Merck: An Adjuvant Treatment Option for Certain Patients with Melanoma after Complete Resection

Chandar Bhimani, MD ### 2262864###Industry Presenter#########
Industry Presenter: Chandar Bhimani, MD
###
Industry Forum: Bristol Myers Squibb:A New Treatment Option: Adjuvant Nivolumab Following Complete Resection for Stage IIB/C Melanoma

Steven L. McCune, MD, PhD – Northwest Georgia Oncology Center ### 2275112###Industry Presenter######Northwest Georgia Oncology Center###
Industry Presenter: Steven L. McCune, MD, PhD – Northwest Georgia Oncology Center
###
Industry Patient Spotlight Presented by SpringWorks: Hear from a Desmoid Tumor Patient Speaker

DeAnn :Patient Speaker, Patient ### 2275120###HUB Presenter#########
HUB Presenter: DeAnn :Patient Speaker, Patient
###
Industry Spotlight Presented by Elucent: EnVision: Tailored Precision for Every Patient, Every Time.

Lee G. Wilke, MD (she/her/hers) – University of Wisconsin, School of Medicine and Public Health, Madison, WI ### 937393###HUB Presenter###Surgical Oncologist###University of Wisconsin, School of Medicine and Public Health, Madison, WI###
HUB Presenter: Lee G. Wilke, MD (she/her/hers) – University of Wisconsin, School of Medicine and Public Health, Madison, WI
### she/her/hers
Industry Spotlight Presented by Natera: Tumor-Informed Residual Disease (MRD) Testing to Guide Perioperative Decisions in Solid Tumors

Michael Krainock, MD, PhD – Natera, Inc. ### 1594540###HUB Presenter###Medical Director, Oncology###Natera, Inc.###
HUB Presenter: Michael Krainock, MD, PhD – Natera, Inc.
###
Industry Spotlight Presented by Pacira: Getting to NOPAIN: Enhancing outcomes with advanced pain management techniques to allow for migration to the hospital outpatient setting

Uma L. Shastri, MD, FRCPC – Northside Anesthesiology Consultants ### 2275117###HUB Presenter###Anesthesiologist###Northside Anesthesiology Consultants###
HUB Presenter: Uma L. Shastri, MD, FRCPC – Northside Anesthesiology Consultants
###
Industry Spotlight Presented by Replimune: The Role of Oncolytic Immunotherapy in Oncology: Focus on Melanoma

Giuseppe Gullo, MD – Replimune ### 2275118###HUB Presenter###Executive Medical Director, Clinical Development###Replimune###
HUB Presenter: Giuseppe Gullo, MD – Replimune
###
Industry Spotlight Presented by SpringWorks: Presentation on OGSIVEO (nirogacestat), the first and only FDA-approved therapy for adult patients with progressing desmoid tumors who require systemic treatment.

Jeffrey D. Wayne, MD (he/him/his) – Department of Surgery - Northwestern Memorial Hospital ### 2170407###Industry Presenter###Chief of Division of Surgical Oncology, Professor of Surgery and Dermatology###Department of Surgery - Northwestern Memorial Hospital###
Industry Presenter: Jeffrey D. Wayne, MD (he/him/his) – Department of Surgery - Northwestern Memorial Hospital
### he/him/his
Intraoperative Chemotherapy Consideration for Colorectal Cancer

Maria Citarella Russell, MD – Emory University ### 937364###Presenter###Professor###Emory University###
Presenter: Maria Citarella Russell, MD – Emory University
###
Introduction to Session

Ali Landman, PhD (she/her/hers) – The Lancet Oncology ### 2133403###Breakout Presenter###Deputy Editor###The Lancet Oncology###
Breakout Presenter: Ali Landman, PhD (she/her/hers) – The Lancet Oncology
### she/her/hers